EBSAM
CC icon

Eubel Brady & Suttman Asset Management’s Chemours CC Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-62
Closed -$2K – 109
2021
Q2 		$2K Buy
+62
New +$2.05K ﹤0.01% 604

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's CC Position: Q3 2021 in Review

Eubel Brady & Suttman Asset Management sold out of Chemours (CC) in Q3 2021, closing a stake of 62 shares — an estimated $2K sold.

Eubel Brady & Suttman Asset Management first reported a position in CC in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 460 funds tracked by Wall St. Rank hold CC as of Q3 2021.

  • Eubel Brady & Suttman Asset Management reported no remaining Chemours position as of Q3 2021 after selling out during the quarter.
  • Eubel Brady & Suttman Asset Management sold 62 Chemours shares in Q3 2021, an estimated $2K.
  • Eubel Brady & Suttman Asset Management first reported a position in Chemours in Q2 2021 and held it in 1 quarter.
  • Eubel Brady & Suttman Asset Management's Chemours position peaked at $2K in Q2 2021.
  • 460 funds tracked by Wall St. Rank held Chemours as of Q3 2021.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.